Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

CompletedOBSERVATIONAL
Enrollment

363

Participants

Timeline

Start Date

April 11, 2012

Primary Completion Date

December 3, 2013

Study Completion Date

July 4, 2015

Conditions
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple MyelomaLeuklemia, Lymphocytic, Chronic
Interventions
OTHER

Geriatric Assessment of Health Status Scale administration

Scale will be administered to all patients (3 cohorts) at baseline and then after 5 and not more than 15 days

Trial Locations (22)

15006

C.H. Universitario A Coruna, A Coruña

18014

Hospital Virgen de las Nieves, Granada

20080

Hospital de Donostia, Donostia / San Sebastian

25198

Arnau de Vilanova, Lleida

28007

Hospital U. Gregorio Maranon, Madrid

28031

Hospital Infanta Leonor, Madrid

28222

Hospital U. Puerta de Hierro, Majadahonda

31008

C.H. Navarra, Pamplona

33006

Hospital Universitario Central de Asturias, Oviedo

38010

Hospital Ntra. Sra. La Candelaria, Santa Cruz de Tenerife

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

40002

Hospital de Segovia, Segovia

41013

Hospital Virgen del Rocio, Seville

46026

Hospital La Fe, Valencia

46600

Hospital La Ribera, Alzira

01009

Hospital Txagorritxu, Vitoria-Gasteiz

08950

Hospital Sant Joan de Deu, Espluges de Llobregat

08908

Hospital Duran I Reynals, L'Hospitalet de Llobregat

08208

Hospital Parc Tauli, Sabadell

08916

Hospital Germans Trias i Pujol, Badalona

08035

Hospital Vall d'Hebron, Barcelona

08036

Hospital Clinic, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY

NCT02164071 - Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies | Biotech Hunter | Biotech Hunter